Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...
Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...
Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] ...
Peethaambaran Kunnathoor, Chennai Friday, January 31, 2025, 08:00 Hrs [IST] ...
Healthcare sector faces challenges in leprosy elimination with hidden cases & delayed detection: Nandita Vijayasimha, Bengaluru Friday, January 31, 2025, 08:00 Hrs [IST] Indian he ...
Dr Geethika Nutakki: Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] India is on the brink of a healthcare ...
Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...
Quantum-Si and IDEX Health & Science partner to develop & manufacture optics module for Proteus instrument: Branford, Connecticut Thursday, January 30, 2025, 16:00 Hrs [IST] Quant ...
Roche Pharma India appoints Rajwinder as new country general manager to propel growth and innovation
Roche Pharma India appoints Rajwinder as new country general manager to propel growth and innovation: Our Bureau, Bengaluru ...
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis: Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hr ...
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
The World Health Organization (WHO) expresses deep concern about the implications of the immediate funding pause for HIV programmes in low- and middle-income countries. These programmes provide access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback